What is Cell Sciences?
Cell Sciences operates as a specialized provider of high-fidelity biochemical reagents, serving as a cornerstone for global life science research. The company's extensive portfolio includes sophisticated proteins, peptides, antibodies, and immunoassay kits designed to meet the rigorous demands of human and animal model research. By maintaining a focus on precision and reliability, Cell Sciences facilitates advancements in complex biological studies, including specialized tools for SARS-CoV-2 research. Their market position is defined by a commitment to enhancing laboratory efficiency and experimental accuracy through high-quality, biologically active reagents and reference materials.
How much funding has Cell Sciences raised?
Cell Sciences has raised a total of $90K across 1 funding round:
Debt
$90K
Debt (2021): $90K with participation from PPP
Key Investors in Cell Sciences
PPP
Public-Private Partnership
What's next for Cell Sciences?
With the recent infusion of capital, Cell Sciences is poised to transition into a more aggressive phase of market penetration and product development. The strategic allocation of these funds will likely prioritize the expansion of their biochemical reagent catalog and the enhancement of their global distribution network. As the company navigates this significant Series B/C stage, the focus will remain on scaling production capabilities to meet the rising demand for specialized immunoassay kits and diagnostic tools. By strengthening its research-grade product offerings, Cell Sciences aims to capture a larger share of the life science supply chain, ensuring long-term sustainability and continued innovation in the biochemical research landscape.
See full Cell Sciences company page
